Ascendis Pharma A/S

SecurityASND / Ascendis Pharma A/S
InstitutionCutler Group LP
Latest Disclosed Ownership440 shares
Latest Disclosed Value $ 66
Cutler Group LP ownership in ASND / Ascendis Pharma A/S

On April 19, 2024 - Cutler Group LP filed a 13F-HR form disclosing ownership of 440 shares of Ascendis Pharma A/S (US:ASND) valued at $66,515 USD as of March 31, 2024. The entity filed a previous 13F-HR on January 18, 2024 disclosing 0 shares of Ascendis Pharma A/S. The current value of the position is $92,598 USD.

Cutler Group LP has a history of taking positions in derivatives of the underlying security (ASND) in the form of stock options. The firm currently holds call options representing 2,100 of underlying shares valued at $6 USD and put options representing 3,000 of underlying shares valued at $7 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ASND / Ascendis Pharma A/S Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-04-19 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 440 440 0 0.0215
2024-01-18 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -200 -100.00 0 0.0000
2023-11-07 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 200 -460 -69.70 0 0.0018
2023-07-18 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 660 510 340.00 0 0.0081
2023-05-01 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 150 -50 -25.00 0 0.0017
2023-02-07 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 200 200 0 0.0020
2022-10-25 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -1,772 -100.00 0 -100.00
2022-08-04 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,772 -7,883 -81.65 164 -85.53 0.0114
2022-04-14 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 9,655 9,655 1,133 0.0597
2022-01-18 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -150 -100.00 0 -100.00
2021-10-26 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 150 150 23 0.0010
2021-01-21 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -420 -100.00 0 -100.00
2020-10-27 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 420 420 64 0.0039
2020-07-22 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -2,000 -100.00 0 -100.00
2020-05-07 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 2,000 2,000 225 0.0116
2019-05-10 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -1,200 -100.00 0 -100.00
2019-02-05 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,200 1,200 75 0.0071
2018-11-07 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -800 -100.00 0 -100.00
2018-08-10 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 800 800 53 0.0042
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-04-19 2024-03-31 13F ASCENDIS PHARMA A Call Call 2,100 0 n/a n/a n/a
2023-11-07 2023-09-30 13F ASCENDIS PHARMA A Call Call 0 -100.00 0 n/a n/a n/a
2023-07-18 2023-06-30 13F ASCENDIS PHARMA A Call Call 400 0.00 0 n/a n/a n/a
2023-05-01 2023-03-31 13F ASCENDIS PHARMA A Call Call 400 -33.33 0 n/a n/a n/a
2023-02-07 2022-12-31 13F ASCENDIS PHARMA A Call Call 600 -83.33 0 -100.00 n/a n/a n/a
2022-10-25 2022-09-30 13F ASCENDIS PHARMA A Call Call 3,600 50 n/a n/a n/a
2022-08-04 2022-06-30 13F ASCENDIS PHARMA A Call Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-04-14 2022-03-31 13F ASCENDIS PHARMA A Call Call 31,500 12 n/a n/a n/a
2022-01-18 2021-12-31 13F ASCENDIS PHARMA A Call Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-26 2021-09-30 13F ASCENDIS PHARMA A Call Call 300 3 n/a n/a n/a
2021-07-19 2021-06-30 13F ASCENDIS PHARMA A Call Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-04-26 2021-03-31 13F ASCENDIS PHARMA A Call Call 3,000 0.00 26 -79.37 n/a n/a n/a
2021-01-21 2020-12-31 13F ASCENDIS PHARMA A Call Call 3,000 150.00 126 4,100.00 n/a n/a n/a
2020-10-27 2020-09-30 13F ASCENDIS PHARMA A Call Call 1,200 -60.00 3 -94.64 n/a n/a n/a
2020-07-22 2020-06-30 13F ASCENDIS PHARMA A S Call Call 3,000 -33.33 56 55.56 n/a n/a n/a
2020-05-07 2020-03-31 13F ASCENDIS PHARMA A S Call Call 4,500 -69.18 36 -89.86 n/a n/a n/a
2020-02-06 2019-12-31 13F ASCENDIS PHARMA A S Call Call 14,600 386.67 355 17,650.00 n/a n/a n/a
2019-10-28 2019-09-30 13F ASCENDIS PHARMA A S Call Call 3,000 -67.39 2 -97.18 n/a n/a n/a
2019-08-09 2019-06-30 13F ASCENDIS PHARMA A S Call Call 9,200 -69.13 71 -84.01 n/a n/a n/a
2019-05-10 2019-03-31 13F ASCENDIS PHARMA A S Call Call 29,800 69.32 444 492.00 n/a n/a n/a
2019-02-05 2018-12-31 13F ASCENDIS PHARMA A S Call Call 17,600 193.33 75 87.50 n/a n/a n/a
2018-11-07 2018-09-30 13F ASCENDIS PHARMA A S Call Call 6,000 361.54 40 1,233.33 n/a n/a n/a
2018-08-10 2018-06-30 13F ASCENDIS PHARMA A S Call Call 1,300 3 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-04-19 2024-03-31 13F ASCENDIS PHARMA A Put Put 3,000 0 n/a n/a n/a
2023-02-07 2022-12-31 13F ASCENDIS PHARMA A Put Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-10-25 2022-09-30 13F ASCENDIS PHARMA A Put Put 3,000 4 n/a n/a n/a
2022-08-04 2022-06-30 13F ASCENDIS PHARMA A Put Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-04-14 2022-03-31 13F ASCENDIS PHARMA A Put Put 5,800 4 n/a n/a n/a
2022-01-18 2021-12-31 13F ASCENDIS PHARMA A Put Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-26 2021-09-30 13F ASCENDIS PHARMA A Put Put 900 5 n/a n/a n/a
2021-07-19 2021-06-30 13F ASCENDIS PHARMA A Put Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-04-26 2021-03-31 13F ASCENDIS PHARMA A Put Put 3,000 0.00 14 600.00 n/a n/a n/a
2021-01-21 2020-12-31 13F ASCENDIS PHARMA A Put Put 3,000 2 n/a n/a n/a
2020-10-27 2020-09-30 13F ASCENDIS PHARMA A S Put Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-22 2020-06-30 13F ASCENDIS PHARMA A S Put Put 2,000 -61.54 3 -96.25 n/a n/a n/a
2020-05-07 2020-03-31 13F ASCENDIS PHARMA A S Put Put 5,200 2,500.00 80 n/a n/a n/a
2020-02-06 2019-12-31 13F ASCENDIS PHARMA A S Put Put 200 0 n/a n/a n/a
2019-10-28 2019-09-30 13F ASCENDIS PHARMA A S Put Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-09 2019-06-30 13F ASCENDIS PHARMA A S Put Put 10,300 -51.87 5 -86.49 n/a n/a n/a
2019-05-10 2019-03-31 13F ASCENDIS PHARMA A S Put Put 21,400 96.33 37 -47.89 n/a n/a n/a
2019-02-05 2018-12-31 13F ASCENDIS PHARMA A S Put Put 10,900 45.33 71 77.50 n/a n/a n/a
2018-11-07 2018-09-30 13F ASCENDIS PHARMA A S Put Put 7,500 200.00 40 233.33 n/a n/a n/a
2018-08-10 2018-06-30 13F ASCENDIS PHARMA A S Put Put 2,500 12 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.